{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:12:22Z","timestamp":1789866742726,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100016341","name":"Korea University Guro Hospital","doi-asserted-by":"crossref","award":["2020GR0238"],"award-info":[{"award-number":["2020GR0238"]}],"id":[{"id":"10.13039\/100016341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00428-020-03012-2","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T23:02:48Z","timestamp":1609801368000},"page":"1071-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system"],"prefix":"10.1007","volume":"478","author":[{"given":"Han-Na","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baek-hui","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yeul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeree","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8869-3176","authenticated-orcid":false,"given":"Hayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"3012_CR1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","volume":"30","author":"A Lugli","year":"2017","unstructured":"Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, el Zimaity H, Fl\u00e9jou JF, Hansen TP, Hartmann A, Kakar S, Langner C, Nagtegaal I, Puppa G, Riddell R, Ristim\u00e4ki A, Sheahan K, Smyrk T, Sugihara K, Terris B, Ueno H, Vieth M, Zlobec I, Quirke P (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30:1299\u20131311. https:\/\/doi.org\/10.1038\/modpathol.2017.46","journal-title":"Mod Pathol"},{"key":"3012_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2559.2002.01324.x","volume":"40","author":"H Ueno","year":"2002","unstructured":"Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour `budding\u2019 as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127\u2013132. https:\/\/doi.org\/10.1046\/j.1365-2559.2002.01324.x","journal-title":"Histopathology"},{"key":"3012_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/jcm5050051","volume":"5","author":"AD Grigore","year":"2016","unstructured":"Grigore AD, Jolly MK, Jia D et al (2016) Tumor budding: the name is EMT. Partial EMT. J Clin Med 5:51","journal-title":"J Clin Med"},{"key":"3012_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2015.1129481","volume":"10","author":"H Li","year":"2016","unstructured":"Li H, Xu F, Li S, Zhong A, Meng X, Lai M (2016) The tumor microenvironment: an irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis. Cell Adhes Migr 10:1\u201313","journal-title":"Cell Adhes Migr"},{"key":"3012_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/jso.23694","volume":"110","author":"Y Niwa","year":"2014","unstructured":"Niwa Y, Yamada S, Koike M, Kanda M, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y (2014) Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J Surg Oncol 110:764\u2013769","journal-title":"J Surg Oncol"},{"key":"3012_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fonc.2012.00209","volume":"2","author":"E Karamitopoulou","year":"2013","unstructured":"Karamitopoulou E (2013) Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer. Front Oncol 2:209","journal-title":"Front Oncol"},{"key":"3012_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y (2019) Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell 49:361\u2013374. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.010","journal-title":"Dev Cell"},{"key":"3012_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818\u2013829. https:\/\/doi.org\/10.1016\/j.devcel.2008.05.009","journal-title":"Dev Cell"},{"key":"3012_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2559.2005.02161.x","volume":"47","author":"F Prall","year":"2005","unstructured":"Prall F, Nizze H, Barten M (2005) Tumour budding as prognostic factor in stage I\/II colorectal carcinoma. Histopathology 47:17\u201324. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02161.x","journal-title":"Histopathology"},{"key":"3012_CR10","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.3748\/wjg.v16.i38.4823","volume":"16","author":"I Zlobec","year":"2010","unstructured":"Zlobec I, Molinari F, Martin V, Mazzucchelli L, Saletti P, Trezzi R, de Dosso S, Vlajnic T, Frattini M, Lugli A (2010) Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol 16:4823\u20134831. https:\/\/doi.org\/10.3748\/wjg.v16.i38.4823","journal-title":"World J Gastroenterol"},{"key":"3012_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2018.02.001","volume":"78","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Kim A, Kim YK, Park WY, Kim HS, Jo HJ, Oh N, Song GA, Park DY (2018) The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma. Hum Pathol 78:8\u201317. https:\/\/doi.org\/10.1016\/j.humpath.2018.02.001","journal-title":"Hum Pathol"},{"key":"3012_CR12","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1200\/JCO.18.02059","volume":"37","author":"H Ueno","year":"2019","unstructured":"Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Matsuda C, Nakamoto Y, Kotake M, Kurachi K, Egawa T, Yasumasa K, Murata K, Ikawa O, Shinji S, Murotani K, Matsui S, Teramukai S, Tomita N, Sugihara K, on behalf of the SACURA Study Group (2019) Prospective multicenter study on the prognostic and predictive impact of tumor budding in stage II colon cancer: results from the SACURA trial. J Clin Oncol 37:1886\u20131894. https:\/\/doi.org\/10.1200\/JCO.18.02059","journal-title":"J Clin Oncol"},{"key":"3012_CR13","doi-asserted-by":"publisher","first-page":"151420","DOI":"10.1016\/j.anndiagpath.2019.151420","volume":"43","author":"S Hacking","year":"2019","unstructured":"Hacking S, Angert M, Jin C, Kline M, Gupta N, Cho M, Thomas R, Lee L, Chavarria H, Nasim M (2019) Tumor budding in colorectal carcinoma: an institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases. Ann Diagn Pathol 43:151420. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151420","journal-title":"Ann Diagn Pathol"},{"key":"3012_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.humpath.2018.10.023","volume":"85","author":"H Dawson","year":"2019","unstructured":"Dawson H, Galuppini F, Tr\u00e4ger P, Berger MD, Studer P, Br\u00fcgger L, Zlobec I, Inderbitzin D, Lugli A (2019) Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer. Hum Pathol 85:145\u2013151. https:\/\/doi.org\/10.1016\/j.humpath.2018.10.023","journal-title":"Hum Pathol"},{"key":"3012_CR15","volume-title":"AJCC cancer staging manual, 8th ed. 2017, Corr. 3rd printing 2018 edition","year":"2016","unstructured":"Amin MB, Edge SB, Greene FL et al (eds) (2016) AJCC cancer staging manual, 8th ed. 2017, Corr. 3rd printing 2018 edition. Springer, Chicago"},{"key":"3012_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-011-1131-9","volume":"459","author":"K Kai","year":"2011","unstructured":"Kai K, Kohya N, Kitahara K, Masuda M, Miyoshi A, Ide T, Tokunaga O, Miyazaki K, Noshiro H (2011) Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions. Virchows Arch 459:449\u2013456. https:\/\/doi.org\/10.1007\/s00428-011-1131-9","journal-title":"Virchows Arch"},{"key":"3012_CR17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/jso.24946","volume":"117","author":"S Okubo","year":"2018","unstructured":"Okubo S, Mitsunaga S, Kato Y, Kojima M, Sugimoto M, Gotohda N, Takahashi S, Hayashi R, Konishi M (2018) The prognostic impact of differentiation at the invasive front of biliary tract cancer. J Surg Oncol 117:1278\u20131287. https:\/\/doi.org\/10.1002\/jso.24946","journal-title":"J Surg Oncol"},{"key":"3012_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00428-015-1886-5","volume":"468","author":"L De Smedt","year":"2016","unstructured":"De Smedt L, Palmans S, Sagaert X (2016) Tumour budding in colorectal cancer: what do we know and what can we do? Virchows Arch 468:397\u2013408. https:\/\/doi.org\/10.1007\/s00428-015-1886-5","journal-title":"Virchows Arch"},{"key":"3012_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/bjc.2016.274","volume":"115","author":"AC Rogers","year":"2016","unstructured":"Rogers AC, Winter DC, Heeney A, Gibbons D, Lugli A, Puppa G, Sheahan K (2016) Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer 115:831\u2013840. https:\/\/doi.org\/10.1038\/bjc.2016.274","journal-title":"Br J Cancer"},{"key":"3012_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ctrv.2014.12.007","volume":"41","author":"HC van Wyk","year":"2015","unstructured":"van Wyk HC, Park J, Roxburgh C, Horgan P, Foulis A, McMillan DC (2015) The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review. Cancer Treat Rev 41:151\u2013159. https:\/\/doi.org\/10.1016\/j.ctrv.2014.12.007","journal-title":"Cancer Treat Rev"},{"key":"3012_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/jop.12856","volume":"48","author":"N Xie","year":"2019","unstructured":"Xie N, Yu P, Liu H, Liu X, Hou J, Chen X, Huang H, Wang C (2019) Validation of the International Tumor Budding Consensus Conference (2016) recommendations in oral tongue squamous cell carcinoma. J Oral Pathol Med 48:451\u2013458. https:\/\/doi.org\/10.1111\/jop.12856","journal-title":"J Oral Pathol Med"},{"key":"3012_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/his.13508","volume":"73","author":"E Karamitopoulou","year":"2018","unstructured":"Karamitopoulou E, Wartenberg M, Zlobec I, Cibin S, Worni M, Gloor B, Lugli A (2018) Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system. Histopathology 73:137\u2013146. https:\/\/doi.org\/10.1111\/his.13508","journal-title":"Histopathology"},{"key":"3012_CR23","doi-asserted-by":"publisher","first-page":"e0195451","DOI":"10.1371\/journal.pone.0195451","volume":"13","author":"S Shimizu","year":"2018","unstructured":"Shimizu S, Miyazaki A, Sonoda T, Koike K, Ogi K, Kobayashi JI, Kaneko T, Igarashi T, Ueda M, Dehari H, Miyakawa A, Hasegawa T, Hiratsuka H (2018) Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: with special reference to the mode of invasion and worst pattern of invasion. PLoS One 13:e0195451. https:\/\/doi.org\/10.1371\/journal.pone.0195451","journal-title":"PLoS One"},{"key":"3012_CR24","unstructured":"Viera AJ, Garrett JM Understanding interobserver agreement: the Kappa statistic. Family Medicine 4"},{"key":"3012_CR25","doi-asserted-by":"publisher","unstructured":"te Boekhorst V, Friedl P (2016) Plasticity of cancer cell invasion-mechanisms and implications for therapy. Adv Cancer Res. https:\/\/doi.org\/10.1016\/bs.acr.2016.07.005","DOI":"10.1016\/bs.acr.2016.07.005"},{"key":"3012_CR26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","volume":"147","author":"P Friedl","year":"2011","unstructured":"Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992\u20131009. https:\/\/doi.org\/10.1016\/j.cell.2011.11.016","journal-title":"Cell"},{"key":"3012_CR27","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.22034\/APJCP.2018.19.9.2447","volume":"19","author":"A Mehta","year":"2018","unstructured":"Mehta A, Goswami M, Sinha R, Dogra A (2018) Histopathological significance and prognostic impact of tumor budding in colorectal cancer. Asian Pac J Cancer Prev 19:2447\u20132453. https:\/\/doi.org\/10.22034\/APJCP.2018.19.9.2447","journal-title":"Asian Pac J Cancer Prev"},{"key":"3012_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41379-018-0189-1","volume":"32","author":"M Takamatsu","year":"2019","unstructured":"Takamatsu M, Kawachi H, Yamamoto N, Kobayashi M, Toyama Y, Maekawa T, Chino A, Saito S, Ueno M, Takazawa Y, Ishikawa Y (2019) Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method. Mod Pathol 32:675\u2013683. https:\/\/doi.org\/10.1038\/s41379-018-0189-1","journal-title":"Mod Pathol"},{"key":"3012_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/PAS.0000000000000333","volume":"39","author":"K O\u2019Connor","year":"2015","unstructured":"O\u2019Connor K, Li-Chang HH, Kalloger SE, Peixoto RD, Webber DL, Owen DA, Driman DK, Kirsch R, Serra S, Scudamore CH, Renouf DJ, Schaeffer DF (2015) Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma. Am J Surg Pathol 39:472\u2013478. https:\/\/doi.org\/10.1097\/PAS.0000000000000333","journal-title":"Am J Surg Pathol"},{"key":"3012_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10388-019-00698-5","volume":"17","author":"K Fuchinoue","year":"2020","unstructured":"Fuchinoue K, Nemoto T, Shimada H, Tochigi N, Igarashi Y, Yajima S, Suzuki T, Oshima Y, Shibuya K (2020) Immunohistochemical analysis of tumor budding as predictor of lymph node metastasis from superficial esophageal squamous cell carcinoma. Esophagus 17:168\u2013174","journal-title":"Esophagus"},{"key":"3012_CR31","doi-asserted-by":"crossref","unstructured":"Kairaluoma V, Kemi N, Pohjanen V-M, et al (2020) Tumour budding and tumour\u2013stroma ratio in hepatocellular carcinoma. Br J Cancer 1\u20138","DOI":"10.1038\/s41416-020-0847-1"},{"key":"3012_CR32","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.21873\/anticanres.14240","volume":"40","author":"G Karayannopoulou","year":"2020","unstructured":"Karayannopoulou G, Panteris E, Kanitakis J (2020) Tumour budding is an independent predictive factor of cutaneous squamous-cell carcinoma aggressiveness. Anticancer Res 40:2695\u20132699","journal-title":"Anticancer Res"},{"key":"3012_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41379-019-0413-7","volume":"33","author":"C Neppl","year":"2020","unstructured":"Neppl C, Zlobec I, Schmid RA, Berezowska S (2020) Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung\u2014a single-center analysis of 354 cases. Mod Pathol 33:802\u2013811","journal-title":"Mod Pathol"},{"key":"3012_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10549-015-3333-3","volume":"150","author":"B Salhia","year":"2015","unstructured":"Salhia B, Trippel M, Pfaltz K, Cihoric N, Grogg A, L\u00e4drach C, Zlobec I, Tapia C (2015) High tumor budding stratifies breast cancer with metastatic properties. Breast Cancer Res Treat 150:363\u2013371. https:\/\/doi.org\/10.1007\/s10549-015-3333-3","journal-title":"Breast Cancer Res Treat"},{"key":"3012_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.prp.2013.01.009","volume":"209","author":"F Liang","year":"2013","unstructured":"Liang F, Cao W, Wang Y, Li L, Zhang G, Wang Z (2013) The prognostic value of tumor budding in invasive breast cancer. Pathol Res Pract 209:269\u2013275. https:\/\/doi.org\/10.1016\/j.prp.2013.01.009","journal-title":"Pathol Res Pract"},{"key":"3012_CR36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/PAS.0b013e3181ae29d6","volume":"33","author":"A Suzuki","year":"2009","unstructured":"Suzuki A, Togashi K, Nokubi M, Koinuma K, Miyakura Y, Horie H, Lefor AT, Yasuda Y (2009) Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am J Surg Pathol 33:1601\u20131607. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ae29d6","journal-title":"Am J Surg Pathol"},{"key":"3012_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/modpathol.2012.155","volume":"26","author":"E Karamitopoulou","year":"2013","unstructured":"Karamitopoulou E, Zlobec I, K\u00f6lzer V, Kondi-Pafiti A, Patsouris ES, Gennatas K, Lugli A (2013) Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer. Mod Pathol 26:295\u2013301. https:\/\/doi.org\/10.1038\/modpathol.2012.155","journal-title":"Mod Pathol"},{"key":"3012_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00428-018-2341-1","volume":"473","author":"B Martin","year":"2018","unstructured":"Martin B, Sch\u00e4fer E, Jakubowicz E, Mayr P, Ihringer R, Anthuber M, Schenkirsch G, Schaller T, M\u00e4rkl B (2018) Interobserver variability in the H&E-based assessment of tumor budding in pT3\/4 colon cancer: does it affect the prognostic relevance? Virchows Arch 473:189\u2013197. https:\/\/doi.org\/10.1007\/s00428-018-2341-1","journal-title":"Virchows Arch"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-03012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-03012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-03012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T05:09:29Z","timestamp":1623647369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-03012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3012"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-03012-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"23 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of KUGH (approval number: 2020GR0238).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}